Source: Cancers. Unidade: FMRP
Subjects: MEDULOBLASTOMA, GENÔMICA, NEOPLASIAS, BIOMARCADORES, TERAPIA COMBINADA
ABNT
CRUZEIRO, Gustavo Alencastro Veiga; TONE, Luiz Gonzaga; VALERA, Elvis Terci; et al. YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells. Cancers, Basel, v. 13, n. 24, p. 1-11, 2021. Disponível em: < https://doi.org/10.3390/cancers13246249 > DOI: 10.3390/cancers13246249.APA
Cruzeiro, G. A. V., Tone, L. G., Valera, E. T., Scrideli, C. A., Magalhães, T. de A., Sousa, G. R. de, et al. (2021). YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells. Cancers, 13( 24), 1-11. doi:10.3390/cancers13246249NLM
Cruzeiro GAV, Tone LG, Valera ET, Scrideli CA, Magalhães T de A, Sousa GR de, Silva RB, Biagi Junior CAO de, Chagas PF das, Queiroz RG de P. YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells [Internet]. Cancers. 2021 ; 13( 24): 1-11.Available from: https://doi.org/10.3390/cancers13246249Vancouver
Cruzeiro GAV, Tone LG, Valera ET, Scrideli CA, Magalhães T de A, Sousa GR de, Silva RB, Biagi Junior CAO de, Chagas PF das, Queiroz RG de P. YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells [Internet]. Cancers. 2021 ; 13( 24): 1-11.Available from: https://doi.org/10.3390/cancers13246249